Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH
Open Access
- 19 May 2016
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 139 (7), 1557-1563
- https://doi.org/10.1002/ijc.30197
Abstract
Germline mutations in the DNA base excision repair gene MUTYH are known to increase a carrier's risk of colorectal cancer. However, the risks of other (extracolonic) cancers for MUTYH mutation carriers are not well defined. We identified 266 probands (91% Caucasians) with a MUTYH mutation (41 biallelic and 225 monoallelic) from the Colon Cancer Family Registry. Mutation status, sex, age and histories of cancer from their 1,903 first‐ and 3,255 second‐degree relatives were analyzed using modified segregation analysis conditioned on the ascertainment criteria. Compared with incidences for the general population, hazard ratios (HRs) (95% confidence intervals [CIs]) for biallelic MUTYH mutation carriers were: urinary bladder cancer 19 (3.7–97) and ovarian cancer 17 (2.4–115). The HRs (95% CI) for monoallelic MUTYH mutation carriers were: gastric cancer 9.3 (6.7–13); hepatobiliary cancer 4.5 (2.7–7.5); endometrial cancer 2.1 (1.1–3.9) and breast cancer 1.4 (1.0–2.0). There was no evidence for an increased risk of cancers at the other sites examined (brain, pancreas, kidney or prostate). Based on the USA population incidences, the estimated cumulative risks (95% CI) to age 70 years for biallelic mutation carriers were: bladder cancer 25% (5–77%) for males and 8% (2–33%) for females and ovarian cancer 14% (2–65%). The cumulative risks (95% CI) for monoallelic mutation carriers were: gastric cancer 5% (4–7%) for males and 2.3% (1.7–3.3%) for females; hepatobiliary cancer 3% (2–5%) for males and 1.4% (0.8–2.3%) for females; endometrial cancer 3% (2%–6%) and breast cancer 11% (8–16%). These unbiased estimates of both relative and absolute risks of extracolonic cancers for people, mostly Caucasians, with MUTYH mutations will be important for their clinical management.Keywords
Funding Information
- National Cancer Institute (UM1 CA167551)
This publication has 45 references indexed in Scilit:
- French experts report on MUTYH-associated polyposis (MAP)Familial Cancer, 2012
- MUTYH gene variants and breast cancer in a Dutch case–control studyBreast Cancer Research and Treatment, 2012
- Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancerInternational Journal of Cancer, 2010
- Association between monoallelic MUTYH mutation and colorectal cancer risk: a meta-regression analysisFamilial Cancer, 2010
- A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variantsBritish Journal of Cancer, 2010
- Estimating gene penetrance from family dataGenetic Epidemiology, 2010
- Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based studyCancer Causes & Control, 2009
- Germline MutY Human Homologue Mutations and Colorectal Cancer: A Multisite Case-Control StudyGastroenterology, 2009
- Genetic variants in MUTYH are not associated with endometrial cancer riskHereditary Cancer in Clinical Practice, 2009
- Duodenal carcinoma in MUTYH-associated polyposisJournal of Clinical Pathology, 2006